Palbocell 125 MG Capsule 21 is used for managing hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has advanced or spread to other parts of the body. It belongs to a class of medicines known as kinase inhibitors.
This medicine is specifically indicated for postmenopausal women and men with advanced breast cancer, where it works alongside aromatase inhibitors or fulvestrant. In premenopausal or perimenopausal women, it must be used with a luteinising hormone-releasing hormone (LHRH) agonist along with endocrine therapy to ensure the treatment works properly.
Your doctor will determine the appropriate dosage and frequency based on your specific condition and response to treatment. It is crucial to inform your doctor about any pre-existing medical conditions or current medications before starting this treatment. If you notice any side effects while taking this medicine, notify your doctor promptly. Continue taking the medicine for the full duration prescribed by your doctor for optimal results.













































